Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis

Summary

Thrombotic disease in newborn infants is common and serious enough to require effective and safe intervention (1). Flowever, neonatal thrombosis is also sufficiently rare to prompt anecdotal observations rather than controlled clinical trials. While there is an abundance of case reports in the pediatric literature, there is a conspicuous paucity of well-designed studies to guide clinical decision-making (2).

The Subcommittee on Neonatal Hemostasis of the Scientific and Standardization Committee recognizes the need for multicenter controlled clinical trials to determine the risks and benefits of different treatment modalities for neonatal thrombosis. Until such data becomes available, the following recommendations may assist clinicians in the management of newborn infants with thrombotic disease. These recommendations were endorsed by the Subcommittee after careful review of the literature and several consensus meetings.

• References

• 1 Schmidt B, Zipursky A. Thrombotic disease in newborn infants. Clin Perinatol 1984; 1l [phone]
• 2 Schmidt B, Andrew M. Neonatal thrombotic disease: Prevention, diagnosis, and treatment. J Pediatr 1988; 113: 407-410
• 3 Seibert JJ, Thylor BJ, Williamson SL, Williams BJ, Szabo JS, Corbitt SL. Sonographic detection of neonatal umbilical-artery thrombosis: Clinical Correlation. AJR 1987; 148: f965-8
• 4 Vailas GN, Brouillette RT, Scott JP, Shkolnik A, Conway J, Wiringa K. Neonatal aortic thrombosis: recent experience. J Pediatr 1986; 109: 101-108
• 5 McDonald MM, Hathaway WE. Anticoagulant therapy by continuous heparinization in newborn and older infants. J Pediatr 1982; 101: 451-457
• 6 Hathaway W, Corrigan J. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis. Normal coagulation data for fetuses and newborn infants. Thromb Haemostas 1991; 65: 323-325
• 7 Schmidt B, Mitchell L, Ofosu P, Andrew M. Standard assays underestimate the concentration of heparin in neonatal plasma. J Lab Clin Med 1988; ll2: 641-643
• 8 McDonald MM, Jacobson LJ, Hay WWJ, Hathaway WE. Heparin clearance in the newborn. Pediatr Res 1981; 15: 1015-1018
• 9 Andrew M, Ofosu EA, Schmidt B, Brooket L, Hirsh J, Buchanan MR. Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thromb Res 1988; 52: 517-527
• 10 Corrigan JJ. Neonatal thrombosis and the thrombolytic system: Pathophysiology and therapy. Am J Pediatr Hematol Oncol 1988; 10: 83-91
• 11 Andrew M, Schmidt B. Anticoagulant and thrombolytic therapy in the newborn. In: Perinatal Thrombosis and Hemostasis. Suzuki S, Hathaway WE, Bonnar J, Sutor AH. (eds) Springer-Verlag; Tokyo: 1991. pp 113-123
• 12 Marlar RA, Montgomery RR, Broekmans AW. and the Working Party Diagnosis and treatment of homozygous protein C deficiency: Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis. J Pediatr 1989; ll4: 528-534